Relationship between obesity, insulin resistance and cell membrane properties
DOI:
https://doi.org/10.15584/ejcem.2023.2.19Keywords:
insulin resistance, membrane properties, obesityAbstract
Introduction and aim. The obesity is one of the greatest public health problems in developing countries and it is a triggering factor for diabetes associated with insulin resistance. The importance of cell membrane lipids as essential regulators of insulin resistance, since changes in the dynamic properties of the cell membrane (e.g., membrane fluidity), could be one of the events by which obesity affects insulin sensitivity. Thus, the insulin resistance may not only be a cause but also a consequence of lipid disorders such as dyslipidemia and/or cell membrane phospholipid composition change. The modification of plasma membrane lipid composition can change membrane biophysical properties and thus influencing protein-lipid interactions, enzymatic activity and regulation of surface receptors. Alterations in the lipid composition modify the fluidity of plasma membranes and the expression of membrane functions, such as receptor binding and enzyme activities. This review summarizes the current knowledge on the effects of the modulation of plasma membrane lipid composition and membrane fluidity in the functionality of membrane proteins involved in insulin activity, including the insulin receptor, glucose transport and Na+/K+ ATPase and, in turn, the key features of the metabolic syndrome.
Material and methods. References for that article were found through PubMed and Google Scholar, using terms: “obesity”, “insulin resistance” and “membrane properties”. The research was limited to abstracts and available full-text articles.
Analysis of the literature. There is a strong relationship between dietary lipids, membrane lipid profiles and insulin resistance. The changes in the dynamic properties of the cell membrane (e.g., membrane fluidity), could be one of the events by which obesity affects insulin sensitivity. The modification of plasma membrane lipid composition can change membrane biophysical properties and thus influencing protein–lipid interactions, enzymatic activity, and regulation of surface receptors. Modifications of membrane phospholipid composition could have a role in the insulin action by altering membrane fluidity and, as a consequence, the insulin signaling pathway.
Conclusion. As conclusion the membrane-lipid therapy approach can be used to treat important pathologies such as obesity and many others diseases such as : cancer, cardiovascular pathologies, neurodegenerative processes, obesity, metabolic disorders, inflammation, and infectious and autoimmune diseases. This pharmacological strategy aims to regulate cell functions by influencing lipid organization and membrane fluidity, inducing a concomitant modulation of membrane protein localization and activity which might serve to reverse the pathological state. Through this review we suggest an in-depth analysis of the membrane lipid therapy field, especially its molecular bases and its relevance to the development of innovative therapeutic approaches.
Downloads
References
Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973-1974. doi: 10.1001/jama.2015.4260
O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1-12. doi: 10.1111/obr.12229
Fernández-Bergés D, Cabrera de León A, Sanz H, et al. Metabolic syndrome in Spain: prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study. Rev Esp Cardiol (Engl Ed). 2012;65(3):241-248. doi: 10.1016/j.recesp.2011.10.015
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88
Papandreou C, Mourad TA, Jildeh C, Abdeen Z, Philalithis A, Tzanakis N. Obesity in Mediterranean region (1997–2007): a systematic review. Obes Rev Off J Int Assoc Study Obes. 2008;9:389-399. doi: 10.1111/j.1467-789X.2007.00466.x
Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the atherosclerosis risk in communities study. Circulation. 2008;117:754-761. doi: 10.1161/CIRCULATIONAHA.107.716159
Salas J, López Miranda J, Jansen S, et al. The diet rich in monounsaturated fat modifies in a beneficial way carbohydrate metabolism and arterial pressure. Med. Clínica. 1999;113:765–769.
Vessby B, Uusitupa M, Hermansen K, et al. KANWU study, substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia. 2001;44:312-319. doi: 10.1007/s001250051620
Parillo M, Rivellese AA, Ciardullo AV, et al. High-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism. 1992;41:1373-1378. doi: 10.1016/0026-0495(92)90111-m
Schwab U, Lauritzen L, Tholstrup T, et al. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr Res. 2014;58:5-10. doi: 10.3402/fnr.v58.25145
Perona JS, Vögler O, Sánchez-Domínguez JM, Montero E, Escribá PV, Ruiz-Gutierrez V. Consumption of virgin olive oil influences membrane lipid composition and regulates intracellular signaling in elderly adults with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci. 2007;62:256-263. doi: 10.1093/gerona/62.3.256
Haag M, Dippenaar NG. Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. Med Sci Monit Int Med J Exp Clin Res. 2005;11:RA359–RA367.
Chabowski A, Zendzian-Piotrowska M, Konstantynowicz K, et al. Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes. Acta Physiol. 2013;207:346-357. doi: 10.1111/apha.12022
Tsuchiya A, Nagaya H, Kanno T, et al. Oleic acid stimulates glucose uptake into adipocytes by enhancing insulin receptor signaling. J Pharmac Sci. 2014;126:337-343. doi: 10.1254/jphs.14182FP
Barceló F, Perona JS, Prades J, et al. Mediterranean-style diet effect on the structural properties of the erythrocyte cell membrane of hypertensive patients: the Prevencion con Dieta Mediterranea Study. Hypertens. Dallas Tex. 1979;54:1143-1150. doi: 10.1161/HYPERTENSIONAHA.109.137471
Younsi M, Quilliot D, Al-Makdissy N, et al. Erythrocyte membrane phospholipid composition is related to hyperinsulinemia in obese nondiabetic women: effects of weight loss. Metabolism. 2002;51:1261-1268. doi: 10.1053/meta.2002.35184
Gunes O, Tascilar E, Sertoglu E, et al. Associations between erythrocyte membrane fatty acid compositions and insulin resistance in obese adolescents. Chem Phys Lipids. 2014;184:69-75. doi: 10.1016/j.chemphyslip.2014.09.006
Min Y, Ghebremeskel K, Lowy C, Thomas B, Crawford M. Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. Diabetologia. 2004;47:75-81. doi: 10.1007/s00125-003-1275-5
Cazzola R, Rondanelli M, Russo-Volpe S, Ferrari E, Cestaro B. Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res. 2004;45:1846-1851. doi: 10.1194/jlr.M300509-JLR200
Pietiläinen K, Róg T, Seppänen-Laakso T, et al. Remodeling of Adipose Tissue Lipidome as Adaptation to Acquired Obesity: Benefits and Costs. In: Proceedings of the Metabolomics 2010: Breakthroughs in Plant, Microbial and Human Biology, Clinical and Nutritional Research, and Biomarker Discovery. Amsterdam, The Netherlands, 2010;164.
Arranz S, Jauregibeitia I, Tueros I, Amezaga J, Uriarte M. Lipidomic membrane as a molecular basis for precision nutrition in childhood obesity. Proc Nutr Soc. 2019;78:E7. doi: 10.1080/15548627.2020.1797280
Jauregibeitia I, Portune K, Rica I, et al. Fatty Acid Profile of Mature Red Blood Cell Membranes and Dietary Intake as a New Approach to Characterize Children with Overweight and Obesity. Nutrients. 2020;12:3446. doi: 10.3390/nu12113446
Maulucci G, Cohen O, Daniel B, et al. Fatty acid-related modulations of membrane fluidity in cells: Detection and implications. Free Radic Res. 2016;50(1):40-50. doi: 10.1080/10715762.2016.1231403
Romero LO, Massey AE, Mata-Daboin AD, et al. Dietary fatty acids fine-tune Piezo1 mechanical response. Nat Commun. 2019;10:1200. doi: 10.1038/s41467-019-09055-7
Yang X, Sheng W, Sun GY, Lee JC. Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase dependent amyloid precursor protein processing. Neurochem Int. 2011;58:321-329. doi: 10.1016/j.neuint.2010.12.004
Wiernsperger NF. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes. Diabetes Metab. 1999;25:110-127.
Neufeld ND, Bush MA, Corbo L, Brunnerman S. Changes in monocyte insulin binding and membrane physical properties after a very low caloric food supplement diet. Clin Res. 1984;32:235A.
Ahyayauch H, Larijane B, Alonso A, Goñi FM. Detergent solubilization of phosphatidylcholine bilayers in the fluid state: influence of the acyl chain structure. Biochum Biophys Acta. 2006;1759:190-196. doi: 10.1016/j.bbamem.2006.01.016
Beguinot F, Tramontano D, Duilio C, et al. Alteration of erythrocyte membrane lipid fluidity in human obesity. J Clin Endocrino Metab. 1985;60:1226-1230. doi: 10.1210/jcem-60-6-1226
Cooper RA, Diloy-Puray M, Lando P, Greenberg MS. An analysis of lipoprotein, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease. J Clin Invest. 1972;51:3182. doi: 10.1172/JCI107145
Cooper RA. Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med. 1977;297:371. doi: 10.1056/NEJM197708182970707
Sot J, García-Arribas A, Abad B, et al. Erythrocyte membrane nanomechanical rigidity is decreased in obese patients. Int J Mol Sci. 2022;23:1920. doi: 10.3390/ijms23031920
Kinnunen PJ. On the principles of functional ordering in biological membranes. Chem Phys Lipids. 1991;57:375-399. doi: 10.1016/0009-3084(91)90087-r
Turk J, Colca JR, Kotagal N, MeDaniel ML. Arachidonic acid metabolism in isolated pancreatic islets. II. The effects of glucose and of inhibitors of arachidonate metabolism on insulin secretion and metabolite synthesis. Biochim Biophys Acta. 1984;794:125-136. doi: 10.1016/0005-2760(84)90305-9
Wolf BA, Pasquale SM, Turk J. Free fatty acid accumulation in secretagogue-stimulated pancreatic islets and effects of arachidonate on depolarization-induced insulin secretion. Biochemistry. 1991;6372-6379. doi: 10.1021/bi00240a004
Kibbey RG, Pongratz RL, Romanelli AJ, et al. Mitochondrial GTP regulates glucose-stimulated insulin secretion. Cell Metab. 2007;5:253-264. doi: 10.1016/j.cmet.2007.02.008
Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes. 2000;49:1751-176. doi: 10.2337/diabetes.49.11.1751
Band M, Jones PM, Howell SL. The mechanism of arachidonic acid-induced insulin secretion from rat islets of Langerhans. Biochim Biophys Acta. 1993;1176:64-68. doi: 10.1016/0167-4889(93)90178-r
Creutz CE. Cis-Unsaturated fatty acids induce the fusion of chromaffin granules aggregated by synexin. J Cell Biol. 1981;91:247-256. doi: 10.1083/jcb.91.1.247
Storlien LH, Pan DA, Kriketos AD, et al. Skeletal muscle membrane lipids and insulin resistance. Lipids. 1996;31:S261-S265. doi: 10.1016/j.metabol.2021.154803
Winter PW, Van Orden AK, Roess DA, Barisas BG. Actin-dependent clustering of insulin receptors in membrane microdomains. Biochim. Biophys Acta. 2012;1818:467-473. doi: 10.1016/j.bbamem.2011.10.006
Ginsberg BH, Brown TJ, Simon I, Spector AA. Effect of the membrane lipid environment on the properties of insulin receptors. Diabetes. 1981;30:773-780. doi: 10.2337/diab.30.9.773
Elmendorf JS. Fluidity of insulin action. Mol Biotechnol. 2004;27:127-138. doi: 10.1385/MB:27:2:127
Tong P, Thomas T, Berrish T, et al. Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet. 1995;345:357-358. doi: 10.1016/s0140-6736(95)90343-7
Lonnroth P. Regulation of insulin action at the cellular level. J Intern Med. 1991;229:23-29.
Therien AG, Blostein, R, Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol. 2000;279:C541-C566. doi: 10.1152/ajpcell.2000.279.3.C541
Kaplan JH. Biochemistry of Na,K-ATPase. Ann Rev Biochem. 2002;71:511-535. doi: 10.1146/annurev.biochem.71.102201.141218
Grunfeld C, Baird KL, Kahn CR. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and action. Biochem Biophys Res Commun. 1981;103:219. doi: 10.1016/0006-291x(81)91682-x
Gould RJ, Ginsberg BH, Spector AA. Lipid effects on the binding properties of a reconstituted insulin receptor. J Biol Chem. 1982;257:477.
Grisham CM, Barnett RE. The role of lipid-phase transitions in the regulation of the (sodium + potassium) adenosine triphosphatase. Biochemistry. 1973;12:2635. doi: 10.1021/bi00738a013
Witthan R, Blond DM. Respiratory control by an adenosine triphosphatase involved in active transport in brain cortex. Biochem J. 1965;92:147. doi: 10.1042/bj0920147
Iannello S, Campione R, Volpicelli G, Prestipino M, Belfiore F. Na,K-adenosine triphosphatase in mouse and human obesity and diabetes, as related to insulin, NEFA and hypertension. Diabetologia. 1994;37:A133.
Iannello S, Milazzo P, Belfiore F. Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects. Obesity Reviews. 2007;8:231–251. doi: 10.1111/j.1467-789X.2006.00276.x
Iannello S, Milazzo P, Belfiore F. Animal and human tissue Na,K-ATPase in obesity and diabetes: a new proposed enzyme regulation. Am J Med Sci. 2007;333:1-9. doi: 10.1097/00000441-200701000-00001
Oishi K, Zheng B, Kuo JF. Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine and oleic acid. J Biol Chem. 1990;265:70-75.
Pessin J, Thurmond D, Elmendorf J, Coker K, Okada S. Molecular basis of insulin- stimulated GLUT4 vesicle trafficking: location! Location! J Biol Chem. 1999;274:2593-2596. doi: 10.1074/jbc.274.5.2593
Weijers RNM. Lipid composition of cell membranes and its relevance in type 2 diabetes mellitus. Curr Diabetes Rev. 2012;8:390-400. doi: 10.2174/157339912802083531
Satoh S, Nishimura H, Clark AE. Use of bismannose photolabel to elucidate insulin regulated GLUT4 subcellular trafficking kinetics in rat adipose cells: evidence that exocytosis is a critical site of hormone action. J Biol Chem. 1993;268(24):17820-17829.
Jhun BH, Rampal AL, Liu H, Lachaal M, Jung CY. Effects of insulin on steady state kinetics of GLUT4 subcellular distribution in rat adipocytes: evidence of constitutive GLUT4 recycling. J Biol Chem. 1992;267:710-715.
Yang J, Holman GD. Comparison of GLUT4 and GLUT1 subcellular trafficking in basal and insulin-stimulated 3T3-L1 cells. J Biol Chem. 1993;268:4600-4603. doi: 10.1128/MCB.21.14.4785-4806.2001
Czech MP, Buxton JM. Insulin action on the internalization of the GLUT4 glucose transporter in isolated rat adipocytes. J Biol Chem. 1993;268:9187-9190.
Pilch PF, Thompson PA, Czech MP. Coordinate modulation of D-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proc Natl Acad Sci USA. 1980;77:915-918. doi: 10.1073/pnas.77.2.915
Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes. 1992;41:465-475. doi: 10.2337/diab.41.4.465
Shigematsu S, Watson RT, Khan AH, Pessin JE. The adipocyte plasma membrane caveolin functional/structural organization is necessary or the efficient endocytosis of GLUT4. J Biol Chem. 2003;278:10683-10690. doi: 10.1074/jbc.M208563200
Subtil A, Gaidarov I, Kobylarz K, Lampson MA, Keen JH, McGraw TE. Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc Natl Acad Sci USA. 1999;96:6775-6780. doi: 10.1073/pnas.96.12.677
Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 1999;103:253-259. doi: 10.1172/JCI5001
Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA. 1997;94:4318-4323. doi: 10.1073/pnas.94.9.4318
Haag M, Dippenaar NG. Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. Med Sci Monit. 2005;11(12):RA359-RA367.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
